-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 NAR+SoXtPvYQjkMjsbdHDgM7L6GucsZiNsZwqp5SWrp1Hz+5eXEAQz/UoIf8+GaJ
 9lXWVae8NTKkwLBcxKN7ew==

<SEC-DOCUMENT>0001362310-09-008140.txt : 20090522
<SEC-HEADER>0001362310-09-008140.hdr.sgml : 20090522
<ACCEPTANCE-DATETIME>20090522172035
ACCESSION NUMBER:		0001362310-09-008140
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20090522
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20090522
DATE AS OF CHANGE:		20090522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30489
		FILM NUMBER:		09849988

	BUSINESS ADDRESS:	
		STREET 1:		6400 SOUTH FIDDLER
		STREET 2:		SUITE 1750
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80111
		BUSINESS PHONE:		720-488-1711

	MAIL ADDRESS:	
		STREET 1:		6400 SOUTH FIDDLER
		STREET 2:		SUITE 1750
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80111

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c86070e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">



<DIV style="font-size: 10pt">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>


<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>

<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P align="center" style="font-size: 10pt"><B>Date of Report (Date of
earliest event reported): May 22, 2009 (May 15, 2009)</B>

<P align="center">

<P align="center" style="font-size: 24pt"><B>Lifevantage Corporation<BR></B>
<FONT style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>Colorado</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>000-30489</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>90-0224471</B></TD>
</TR>
<TR valign="top">
    <TD>(State or other Jurisdiction of Incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD>(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD>(IRS Employer Identification No.)</TD>
</TR>
</TABLE>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="49%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>11545 W. Bernardo Court, Suite 301, San Diego, California <BR></B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>92127</B></TD>
</TR>
<TR valign="top">
    <TD>(Address of Principal Executive Offices)</TD>
    <TD>&nbsp;</TD>
    <TD>(Zip Code)</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt">Registrant&#146;s telephone number, including area code: <B>(858) 312-8000</B>


<TABLE border="0" width="30%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="100%">&nbsp;</TD>
</TR>
<TR>
    <TD nowrap style="border-bottom: 1px solid #000000"><B>&nbsp;</B></TD>
</TR>
<TR>
    <TD nowrap>(Former name or former address if changed since last report.)</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

<P align="left" style="font-size: 10pt">
<FONT face="Wingdings">&#111;</FONT> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<P>
<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="left" style="font-size: 10pt"><B>Item&nbsp;2.02 Results of Operations and Financial Conditions</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">On May&nbsp;15, 2009, Lifevantage Corporation issued a press release entitled, &#147;Lifevantage Corporation Announces 3Q FY
2009 Financial and Operating Results&#148;. The press release is attached as Exhibit&nbsp;99.1 hereto, which is furnished under
Item&nbsp;2.02 of this report and shall not be deemed to be &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange
Act of 1934, as amended (the &#147;Exchange Act&#148;) or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;) or
the Exchange Act, regardless of any general incorporation language in such filing.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;7.01 Regulation&nbsp;FD Disclosure</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">On May&nbsp;15, 2009, Lifevantage Corporation issued a press release entitled, &#147;Lifevantage Corporation Announces 3Q FY
2009 Financial and Operating Results&#148;.&nbsp; The press release is attached as Exhibit&nbsp;99.1 hereto, which is furnished under
Item&nbsp;7.01 of this report and shall not be deemed to be &#147;filed&#148; for purposes of Section&nbsp;18 of the Exchange Act or
otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filing. On May
19, 2009, Lifevantage Corporation held a conference call&nbsp;in connection with the press release.&nbsp; Information on how to
access a replay of the call can be found on the Company&#146;s website at <U>www.lifevantage.com</U> on the &#147;Investor Info&#148;
page located under the &#147;Company&#148; tab, until May&nbsp;29, 2009.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01 Exhibits</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">99.1 Press release, dated May&nbsp;15, 2009, entitled, &#147;Lifevantage Corporation Announces 3Q FY 2009 Financial and
Operating Results&#148;.

<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt; display: none">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly authorized.


<P align="left" style="font-size: 10pt">Date: May&nbsp;22, 2009



<P align="left" style="margin-left:45%; font-size: 10pt">LIFEVANTAGE CORPORATION



<P align="left" style="margin-left:45%; font-size: 10pt">By: <U>/s/ Bradford K. Amman</U><BR>
Bradford K. Amman<BR>
Chief Financial Officer<BR>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="center" style="font-size: 10pt"><B>EXHIBIT INDEX</B>



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">99.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Press release, dated May&nbsp;15, 2009, entitled, &#147;Lifevantage Corporation Announces 3Q FY 2009 Financial and
Operating Results&#148;.</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">4




</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>c86070exv99w1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 99.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;99.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><IMG src="c86070p8607001.jpg" alt="(LOGO)">
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">FOR IMMEDIATE RELEASE
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">NEWS</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">May&nbsp;15, 2009
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">OTCBB: LFVN</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>LIFEVANTAGE CORPORATION ANNOUNCES<BR>
3Q FY 2009 FINANCIAL AND OPERATING RESULTS</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>SAN DIEGO, California </B>&#151; <u><B>LifeVantage Corporation (OTCBB: LFVN)</B>,</u> maker of Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP>, today
announced results for its third quarter ended March&nbsp;31, 2009. For the three month period ended
March&nbsp;31, 2009, the Company recorded net revenues of $0.7&nbsp;million and a loss of $(3.1) million, or
$(0.12) per share. For the three month period ended March&nbsp;31, 2008, the Company recorded net
revenues of $0.8&nbsp;million and a loss of $(0.6) million, or $(0.03) per share.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">For the nine month period ended March&nbsp;31, 2009, the Company recorded net revenues of $2.5&nbsp;million
and a loss of $(3.8) million, or $(0.15) per share, of which approximately $1.5&nbsp;million, or $0.06
per share consisted of non-cash expenses. Additionally, approximately $0.5&nbsp;million, or $0.02 per
share consisted of one-time expenses. This compares to net revenues of $2.4&nbsp;million and a loss of
$(1.3) million, or $(0.06) per share for the nine month period ended March&nbsp;31, 2008.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">LifeVantage President and CEO, David W. Brown, commented, &#147;During the third quarter the Company has
been preparing for our entry into network marketing. We successfully raised capital through a
private offering in order to meet the increased expenditures we knew would be necessary to
strengthen our infrastructure, increase inventories, develop new marketing tools and to recruit new
distributors. The third quarter results reflect the costs of preparing the Company for significant
anticipated growth, and we believe that the greatly increased interest in our Company reflects the
fact that there is much excitement about the steps we have taken and the progress we&#146;ve made.&#148;
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">The Company also announced that on May&nbsp;18, it will officially launch its new distributor
compensation plan, as well as its highly anticipated new anti-aging skin cream, and will begin
fulfilling the orders it has received, but not shipped or booked during this pre-launch period.
Brown stated, &#147;We have created impressive momentum. Approximately 2,000 distributors have already
joined the Company, drawn by the science of our flagship product, Protandim<SUP style="font-size: 85%; vertical-align: text-top"><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></SUP>, the
attractiveness of the business opportunity and the strength of our management team. We are
attracting both distributors who have been tremendously successful in network marketing, as well as
those who are entirely new to the industry and who are excited about the opportunity.&#148;
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">Other significant developments in the past quarter include the retention of a country manager for
Mexico and the filing for product registration in Mexico; the addition of internationally-known
physicians, Dr.&nbsp;David Perlmutter and Dr.&nbsp;Arnold Leonard, to the Company&#146;s Scientific Advisory
Board; Emmy award-winning talk show host Montel Williams joined LifeVantage as an independent
distributor; and a new peer reviewed study on Protandim<SUP style="font-size: 85%; vertical-align: text-top"><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></SUP> was released by Louisiana State
University. Approximately 20 additional studies are being independently funded and conducted at
academic institutions and research facilities across the nation.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">A conference call will be held on Tuesday, May&nbsp;19, 2009, at 2:00 p.m. MT (4:00 p.m. ET) to discuss
its third quarter fiscal year 2009 financial and operating results and its launch into network
marketing. Interested parties may listen to the call by dialing 1-877-941-2928. A replay of the
call will be available by telephone until May&nbsp;26, 2009, at 1-800-406-7325 passcode 4081184.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><U><B>About Protandim</B><SUP style="font-size: 85%; vertical-align: text-top"><B><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></B></SUP></U>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">Protandim<SUP style="font-size: 85%; vertical-align: text-top"><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></SUP> is a groundbreaking, clinically proven supplement that provides a substantial
benefit to help with the challenge of healthy aging. This patented antioxidant therapy works in a
very different way than conventional foods such as red wine, oranges, blueberries or other popular
antioxidant supplements; as a result, according to Dr.&nbsp;Joe McCord, is much more effective than
those products or foods in reducing oxidative stress. Protandim<SUP style="font-size: 85%; vertical-align: text-top"><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></SUP> works by increasing the
body&#146;s natural antioxidant protection at the cellular level, triggering cells to produce naturally
occurring protective antioxidant enzymes such as superoxide dismutase (SOD), catalase, and
glutathione synthase. Dr.&nbsp;McCord is a pioneer scientist in the field of oxidative stress and is on
the Company&#146;s Board of Directors.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">A peer-reviewed human study showed that after Protandim<SUP style="font-size: 85%; vertical-align: text-top"><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></SUP> was taken for 30 consecutive
days, the accumulation of lipid peroxidation products (a biochemical marker of aging) was decreased
by an average of 40%, although that reduction may be not be typical for all those who consume the
product. The study also reported that this important marker of aging was decreased after taking
Protandim<SUP style="font-size: 85%; vertical-align: text-top"><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></SUP> to the level of a typical 20&nbsp;year old. Protandim<SUP style="font-size: 85%; vertical-align: text-top"><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></SUP> is currently the
subject of over 20 scientific studies at leading universities and research facilities. For more
information, please visit <U>www.LifeVantage.com</U> or contact Jan Strode (619)&nbsp;890-4040 or Jean Golden
(612)&nbsp;385-2324.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><U><B>About LifeVantage Corporation</B></U>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science-based, natural products
company, dedicated to helping people reach their health and wellness goals through science-based
solutions to oxidative stress. Founded in 2003 and based in San Diego, CA, LifeVantage develops
nutraceutical products, including <U><B>Protandim</B><SUP style="font-size: 85%; vertical-align: text-top"><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></SUP></U><B>, </B>that leverage the company&#146;s expertise and
that are intended to deliver significant health benefits to consumers. For more information, visit
<B>www.LifeVantage.com </B>or contact Jan Strode (619)&nbsp;890-4040 or Jean Golden (612)&nbsp;385-2324.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><I>This press release contains forward-looking statements made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based
on the Company&#146;s current expectations and beliefs concerning future events affecting the Company
and involve known and unknown risks and uncertainties including the risk that sales of our product
may not continue at the levels discussed in this press release. These risks and uncertainties may
cause the Company&#146;s actual results or outcomes to be materially different from those anticipated
and discussed herein. These and other risk factors are discussed in greater detail in the Company&#146;s
Annual Report on </I><I>Form 10-KSB</I><I> for the year ended June&nbsp;30, 2008, the Company&#146;s Quarterly Report on
Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2009 and in other documents filed by the Company from
time to time with the Securities and Exchange Commission. The Company cautions investors not to
place undue reliance on the forward-looking statements contained in this press release. All
forward-looking statements are based on information currently available to the Company, and the
Company undertakes no obligation to revise or update these forward-looking statements.</I>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"># # #
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>CONTACTS:</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>LifeVantage Corporation</B>
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>Jan Strode, Investor Relations</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Telephone: (619)&nbsp;890-4040</B>
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>Jean Golden, Investor Relations</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Telephone: (612)&nbsp;385-2324</B>
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>Bradford Amman, CFO</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Telephone: (303)&nbsp;797-9977</B>
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">LIFEVANTAGE CORPORATION AND SUBSIDIARY<BR>
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="66%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">March 31, 2009</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">June 30, 2008</TD>
    <TD>&nbsp;</TD>
</TR>


<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ASSETS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Cash and cash equivalents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">1,312,793</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">196,883</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Restricted cash</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">770,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Marketable Securities, available for sale</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">580,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,100,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Accounts receivable, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">90,432</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">98,008</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Inventory</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">457,083</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">104,415</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Deferred expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">72,049</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Deposit with manufacturer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,482</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">277,979</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Prepaid expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38,612</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">124,049</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,255,402</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,973,383</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Long-term assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Marketable Securities, available for sale</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">145,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Property and equipment, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">171,929</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">63,559</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Intangible assets, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,194,478</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,270,163</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Deferred debt offering costs, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">129,342</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">193,484</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Deposits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48,263</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48,447</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">TOTAL ASSETS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">5,944,414</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">4,549,036</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">LIABILITIES AND STOCKHOLDERS&#146; (DEFICIT)&nbsp;EQUITY</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Revolving line of credit and accrued interest</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">325,146</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">166,620</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Accounts payable</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">899,465</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">139,803</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Accrued expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">779,428</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">338,268</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Deferred revenue</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">510,765</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Capital lease obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">846</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Equity escrow</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">770,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,774,039</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,156,302</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Long-term liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Convertible debt, net of discount</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">348,175</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">223,484</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Derivative warrant liability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,247,885</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,370,099</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,379,786</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Commitments and contingencies</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Stockholders&#146; (deficit)&nbsp;equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Preferred stock &#151; par value $.001,
50,000,000 shares authorized; no shares
issued or outstanding</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Common stock &#151; par value $.001, 250,000,000
shares authorized; 38,250,402 and 24,766,117
issued and outstanding as of March&nbsp;31, 2009
and June&nbsp;30, 2008, respectively</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38,250</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24,766</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Additional paid-in capital</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14,091,899</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17,902,840</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Accumulated (deficit)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(18,555,834</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(14,758,356</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total stockholders&#146; (deficit)&nbsp;equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(4,425,685</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,169,250</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">TOTAL LIABILITIES AND STOCKHOLDERS&#146; (DEFICIT)&nbsp;EQUITY</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">5,944,414</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">4,549,036</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:45px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">The notes accompanying Form 10-Q are an integral part of these condensed consolidated statements.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">LIFEVANTAGE CORPORATION<BR>
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS<BR>
(Unaudited)
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="44%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6">For the three months ended</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6">For the nine months ended</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000">March 31,</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000">March 31,</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</TD>
    <TD>&nbsp;</TD>
</TR>


<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Sales, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">655,122</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">783,946</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2,507,083</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2,387,677</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cost of sales</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">125,198</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">174,890</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">488,283</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">538,212</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Gross profit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">529,924</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">609,056</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,018,800</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,849,465</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Operating expenses:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Marketing and customer service</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,019,739</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">357,990</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,826,608</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,021,111</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">General and administrative</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,885,630</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">702,404</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,896,456</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,606,926</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Research and development</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34,427</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25,045</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">152,942</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">243,934</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Depreciation and amortization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40,653</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39,581</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">120,081</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">117,988</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total operating expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,980,449</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,125,020</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,996,087</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,989,959</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Operating (loss)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(2,450,525</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(515,964</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(2,977,287</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(1,140,494</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other income and (expense):</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Interest (expense), net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(148,935</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(88,692</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(319,319</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(164,647</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Change in fair value of derivative liability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(500,862</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(500,862</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>


<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>


<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total other (expense)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(649,797</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(88,692</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(820,181</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(164,647</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net (loss)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(3,100,332</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(604,656</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(3,797,468</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(1,305,141</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net (loss)&nbsp;per share, basic and diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">($0.12</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">($0.03</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">($0.15</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">($0.06</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Weighted average shares outstanding, basic
and fully diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25,973,085</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22,464,168</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25,165,481</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22,349,282</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">The notes accompanying Form 10-Q are an integral part of these condensed consolidated statements.
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>c86070p8607001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 c86070p8607001.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@,"
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`%`!#`,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/W\H`*`"@`H`*`"@`H`*`"@"*::*VB>:>1(8HQN=W(55'3D
MGN20`.I)`')K'$8BAA*-3$8FK&A0HJ\YS:C&*VU;[MI);MM))MI%TZ<ZDXTZ
M<'*<M%%*[^[\7V6K)"RHI8D(JC)+$*%'<DG&!6DIQA%SE)0A%7;D^5)=VW9)
M>I*3NHQ6O1+_`"1C3^(-*MB4%P)W7(V6P\W!_P!\83_QZOE\=QGP]@92I_7/
MK56.CAAH^UL_\:M27_@9W4\MQ<TG[+V4>CG[OX?%^!2_X2,,<0VA`[&20#_Q
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M5(U:,U>$X24H23ZQE%M->:9Y,H2IR<)1<)1T<6FFGYIZH?6A(4`%`!0`4`%`
M!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0!GZGJECHUI)>W\ZV
M\$7KR[N?NQ0H.9)6/`4?4X`)'E9SG66\/X"KF.:8F.%PU'OK.<W\-.E!>]4J
M3VC"*ONW:*;75@\%B<=7AAL+2<ZDNBT45UE)[1BNK?XMI'AVK>+;[6[Z&4((
M+"TN$GM;!B2CM$X=)+O81YLAQT!PH)"\Y8_S)G_'V9<29GAZZA]6RK`5X5L-
M@9-N$Y4YJ4:F*Y6O:3=OA3Y*:;4-;SE^C8+(L-EN&G3OSXJM"4*E9:.*DK.-
M*_PQUWWD]7I9*S)J>K:S*%N)Y[DL<I;0JPB7/9+>(8/U()]36N(SO/\`B3$1
MAB\37QDIN\<-1C)4E?91H4E9_P"*2E+O(YE@\#EU-^QI0H);U)-<VG><OR5E
MY'5:?X:U1PI>%+5?6=@K8_ZYIEA]#BOK\JX%X@Q$8RJX>&7TWUQ$N627_7J"
MG->DE$\/$YIA(MJ$W4:_D6G_`($[+[KG46_AP1`>9='/I'&%`^A9C_*OML+X
M?QI)?6,RDY+I2I**^^<I/_R5'C5<PYG[E+E7F_\`)(MMH5L1CS9Q@8X*#K[;
M*]!\#9<X\OUO$I][TU^'LS%8RI!Z0C^/^9EW7A8NI^SW>UAT6:/Y>?\`:C((
M_P"^37BX[PY<HMX+-'&?2->DN7_P*FTU_P"`,[:.:JG93HZ=XO7[G_FC@=8T
MC4-,RUS`1"3@3Q_/!D],N!^[)]&"U^7<0<.9QD5Y8["..';LJ])\]!]DYI)P
M;Z*HH-]+GTV7XS#8IJ-&I[Z^P_=DO1=?^W;F5I?B._T&</;/YEJ6'GV4C'R9
M`>I3_GC+CHZC_>!'%>9D7%^:\+8E5,'4=;!2E>M@YR?LIKJX;^RJVVJ06KTF
MI1T/0Q>4X;,:?)4C[.M%>Y5BO>B^B?\`-'NG\FF>X:3JMGK-E%?63YB?*NAP
M)()1C?#*H/RR*3]""",@@G^F\ASW+^(<MH9GEM3FHU/=E!V52C5C;GI58KX9
MP;UZ234HMQDF_P`[QV"KY=B)X:O'EG#5-?#*+VE%]8O\'=/5-&E7LG(%`!0`
M4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`9VKZOI7A[3+W6=;U&RT?2-+
MMWN]0U/4;F&RL+"UC&9+BZNIW6."%1R7=E`[FM:-"MB*M/#X>E*M6J-1A3A%
MRG*3V48QNVWV2,ZM6EAZ<ZM:I&C2IKFE*348Q2W;;LDO-G&^&?BW\+?&>IC1
M/"'Q#\&>)=7^SS78TS0O$FDZI?\`V6#9Y]P+6SNI)/)C,B;GVX&\9/-=V*R;
M-L!2]OC,LQ.$H)J//5H5*<.:5[+FE%*[L[+J<F'S3+<54]CA,?AZ]6SER4ZL
M)2LMWRQ;=E?5G8ZOK&E>'M+O];UO4;/2-'TNUFO=1U+4+B*TLK*T@4O-<7-Q
M,RI%$J@DEB/3J:X:%"MB*M/#X>E*K6JR484X1<I2D]E&*U;?D==6K2P]*=:M
M4C1I4DY2G)J,8Q6K;;LDCXXOO^"@W[,UCJ4FGIXF\07T44IB.JZ?X1UR;2FP
M<&2*9[:.62'N'6`@CD9%?;4_#?BJ5)5/JE&DVK^SGB*4:B\FDW%/R<CY.?'/
M#E.;@L34DHNW/&C4Y?572DUYJ.I]1V?C_0-5\(:/XUT%KS6='\0Z=:ZIH'V.
MPO%N=1M;Z%9[5Q;30)+:*T;JS&=(]@/(S@'\KXOS=<&8?%2QV!Q.+QV'J3HT
M\%@Z4\17K8B-TZ<?8J<803UG6DU3A'6\I<L9?<Y)AXYVZ$L)7I4L+6A&I[>M
M)4H0I2U4FI\LFVGI!+F;Z)7:\;U0^,/$U[]LO=(U58U)%K:1V-TMM:1M_#&&
MC&Z0C&Z1OF8^@``_DW/)<?\`&>8_7\QR',HTH-K#86&#Q*P^%IO[,%*"O-JW
MM*TO?F_Y8J,5^L8)9!DN&^KX7'8;F:_>576I^TJ2[NTM(_RP6D?-W;U-)\-:
MLMU;&]T34FM/-3[0JQF"3RB?F*L2""`<XXSC'&<UZ>1<&Y]''8-YEPUF,LO5
M6'MXQINC/V3=I.+;BTXKWK*SDERIINZX<=FV!]C56&S&A&OROD?,I14NETKK
M7;RO?4]YLM.L=.C$5C:Q6R8Y\M`&;_?<Y9S_`+Q-?U-EN499DU%4,LP-+!4[
M6?)%*4O\<W><WYSDV?FF(Q6(Q,W*O6E4EYO1>B5DODD7:](YPH`*`"@!CQI(
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MG*]W&-O6X@RA9CETYTX?[7A%*I3:WE%:U*?I)*\5_,EW9]'U_7Y^2!0`4`%`
M!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0!_-G\*OB=\6+OXG_#BTO/B=\0KNSN?
M'?A*WNK2Y\8:_/;7-M-KUA'/;W$$FH%)H)(V9'1@596(((-?U#F^59-3RG,Y
MT\IP=.<,)B'&4</1C*,E2FTXM0333U36J9_.V5YMFL\RRZ$\QQ4H2Q-!2BZ]
M1IIU8IIIRLTUHT]S^DROY>/Z)/*?CEX.U?X@?"'XA^"?#ZVK:SXF\,:CI.FK
M?3FUM#=W2!8A<7`C?R8LCEMC8]*]CA_&T<LSK+,=B.94,)7A4GR*\E%/7EC=
M7?E='EYWA*V-RG,,%AU'VV(HSA!2?+'F:TN[.R\['P1^R)^R%\6_@I\7XO&W
MC.#PM'HL?AC7-)+:1K;7]Y]KU!K$VX%N;"']UBWDW-OXXX.:_0^,^-,FSS)7
M@,#*O[?V]*I:I24(\L.>^O.]?>5E8^%X3X3S?)LV6,QD:,:"HU(?NZO-+FGR
MVTY(Z:/6YZ5_P4=U;4++X):'H]G.\%IXA\=:9:ZLD;%!=V5CINJZG%:2@$;X
M#?VUG,5.06MDS7E>&-*D\^KUYQ3GA<)4E3O]F4YTX.2[/DE**?:3._Q$K5*>
M2T*,).$*^*A&:6EXQA4FHNW3FC%^J1\A?L9?LI_#WXX:+XR\2?$&76I[;1=5
MM="TO2M'U%])4326*7UUJ%W<PQF65ML\$<42LJ#9(SA]RA?M>..,,SX?KX'"
MY8J4)5Z<JLYU(<^BERQA&+:2V;D]]DK:W^3X-X8P&=4<9B<=*HX4)QI0A3ER
M6;CS2E)I7>Z45HM[WTM^SWA'POI?@GPMX>\'Z(+@:1X7T;3M"TP7<HGNOL6F
M6L5I;FYG"()IS%$I=]J[F).!FOPW&XNKCL7B<;7M[;%59U9\JY8\U23E+E5W
M97>BOHC]CPF&I8+"X?!T+^QPM.%*',[RY8145=Z7=EJ[*[.BKF.@*`/Q=_;]
MN?B7X`^,=AK'AOQ]XYT/PYXV\-6E];Z?I'BC7-/TRTU?1F_LK58;:TM;U(8"
M\"Z7<N(U7+WCL1EB3^Y^',<JQ^25*&*R["5\3@*\H.=2A2E.5.K^\IN4I0<G
M9NI%7>BBEL?CW'=7,LNS>G5PV.Q%##XVC&48PK5(0C4I^Y-**DDKKDD[+5R;
M/O\`_8U\?WOQ"_9]\%ZEJVH76IZ[H@U#PMK=]?7$EU>W-[HMY)';W%W<3,TD
MUQ+I4NG2N\C%F:4L2<Y/YSQOEU/*^),=2H4XT<-7Y*]*$$HQC&K%.2C%)))5
M%-))621]WP?F$\PR'!U:LW.O1YZ-24FW)RIR:3;>K;@X-MZNY[%\5_&,?P]^
M&GCKQK(XC;PWX7UC4[7.,/?PV<HTV$9XS+J#VT8]Y!7B9/@GF.:9?@$M,37I
MTY>4')<[^4.9_(]?-,8LORW'8QNWU6C4G'_$HOD7SE9?,_%3]C[5/BS\2_C]
MX,TW5OB1\0=0T/19+SQ?XBM+GQ;X@GL;BST6+S8+6[MGOS'):W.LSZ;`\3J5
M9)F4@@X/[KQK2R;*N',=5H97@Z.(KJ.&HRCAZ,9QE5=G*,E!-2C24Y)K5-)W
M/QSA'$9KF6>X.C5S#$SH4>:O5BZU5QY::NDUS6M*HX1:>C3:/WLK^>#]R"@"
MCJ=A%J>GW>GS`>7<P/%R/N,PS'(/]I)`K#W45YF<Y70SG*L?E6(2]EC:,Z=_
MY)-7A47]ZG-1G'SBCIP>)G@L50Q-+W94)J5MKK[4?24;I^3/D+4$D@EF@DRL
MD$LD3CH1)$Q1L>F&!K^!LTI5,+6Q&&JKDK8:I.E-;.,Z<G"7W23L?N^$<:D*
M=2'P3C&2]))-?@SZJ\*:BVJ^'-'OV.99;*-9CGDSPY@G8^YEB<_C7]P\#9O+
M/.$<@S.I*];$82G&J^]:C>A6;\W4IR;]3\4SO"+`9MC\+%<L*=63@MK0G[\%
M\HR2.AKZL\H^2OVH/VI[/]G"'PW:CP;>^+-8\56^K3::B:E;Z3IED-*:RCD:
M_N&@N)VW/?1E8X8#D(V77C/V/"?",^)GBI?78X&A@Y4U/]VZDY>TYFN2*<8J
MRB[N4NJT9\KQ+Q/3X=6'A]4EB:N)4W!*:IPCR.*?,[2>O,K)1UL]4=I^S)\6
MM=^-GPHTWX@^(=,TO1M1U'6-?LQIVCFZ:SMK73=2EL[51)>2O++,8HP7<[`S
M$E448`X>*LFP^09Q5RW"U:E:E2IT9<]3E4G*<%*6D4DE=Z+73=L[>',UK9SE
M=/'UJ<*,ZE2K%0A?E483<5\3;;LM7IKT1]`U\X>Z%`!0`4`%`!0`4`%`!0!Y
M_P#$/XAZ7\/-+M[NZM+O5-2U![N+2-$L'MXKF\.GV%QJFI7=Q<W<L=OINCZ?
MIEK<7=Y?W#K'!%%P))I889O1RW+:N8U94X3C1I4E%U*D[N,.>:IPBHQ3E.I4
MG)0ITXJ\I/I%2E'@Q^/I9?2C*4)5*D^94Z<;)RY8N<Y-R:C"G3A%SJ3D[1BN
MLG&+X_X=?&RQ\:ZK'H6H:,=`U*\@N+K19K?4)=6T;6$M+2QO[VQM]0N-+TV>
M#6K>PU*RO6LYK)%FM+E;FTFN4BN?LO;F615,!2=>E6]O2IM1J)P5.I2<I3A&
M3A&I5BZ4IPE34XU&XU(N%2,&X<_)E^<PQE54)T?J]22<J;4G.G/EC&4HJ3A3
MDJD8SC/D<$I4Y*<)32GR^X5X)[04`?S-_">W`^*7PU.!QX^\('IZ:_85_4N<
M2_X2<T_[!,1_Z9F?RWD^)OFV5K37%X=?^58'],E?RT?U(>:?&3Q-J_@OX5>/
M_%?A^2"#6O#WA;5M5TN2ZMUNK>.]M+9Y8&FMF91-&'`RA(SZUZF282CC<WR[
M!XA-T,17ITYJ+Y7RRE9VET=NIY6>XNME^3YEC<.U&OA,/4J4W)7BI1C=7CI=
M>74^%?V2?VGOC!\7/BK)X3\<:AH-SHB^%M7U58M-\/PZ9<?;;2YTV.!OM$=P
MY\L)<S93;SD<\5^@<8\*9+DN4+&9?3JPK_6*=.\ZSFN649M^ZTM=%J?GG!?&
M&<YWG#P6.J494(X>K4M"BJ<N:,J:6JD]/>=U8^0_V@OBQ\>_']E_8'Q0T:;3
M_#&E>*[RYT.>7P5>>'!+=VXU"RM574;A0MWNT^69O+7[^/,Y"U]EPWD_#N6S
M^L9374\75P\8U4L3&M:,N24O<CK'WTE=[;=3XCB7/N(L=#ZMFV'E0PE#$2=*
M3PLJ%Y+GC&U222E>#;LM]];&7\$/BU\?_AIH>L:9\(=%FU'2+_5DOM5DA\$W
MOB<1ZD+2&W6-KJU4BV_T6.(^4W/.X?>YVS[)^'<SKT*N<UU1K4Z;C33Q4</>
M',Y7Y9;^\WJO0RR#/^),KP]>EDN'E5H3J*51K"SKVGRI6YHKW?=2?*_7J?L9
M\8OCKH7P-^&-KXW\4PR7NKWMM96FC>'+8K:7NN>(+FS%PUG&)`WV*UAVRRW$
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MWO<+\:U<?BH99FM.%+$U&XT:L$X1G-7_`'=2#^&;L^5QLG)<O*FU?N?^"@_@
M(>)O@W8>++>#??>`/$-K>R.JY9-%UW9I&I`XY""\DTB4]@+<D],CSO#C,/JF
M=U,'*7+3S"C**7_3VE^\A_Y*JB_[>-_$;!NKD<,;"/OY;6C)_P#7JK^[G_Y,
MZ;^1X_\`\$V?%WE_\+)^'TTA`SI?C'38B<`;@=%UDJOU71<X]>>U>UXGX/\`
MY%>8Q5OXF&F__*M/_P!RGA^&&9<[S3+9.SC[/$P6VC_=U?Q]D>Q_\%!_&/\`
M87P6LO"L$ICN_'/B:PL9(U.TOI.B`ZU?D@<E?MD&E(>W[_GKSXOAQ@O;YY/%
MN/N9?0G)>52K^ZC_`.2NH_D>WXCYC]2R2EA8OEJ8^O&%MOW=+][/_P`F5-?]
MO'B_[`'A23POX%^+OQB;3Q=74=I<:)H4#N;<74'AS3I=>U2W6;RW,4=U?S:;
M`9`C;39GABN*]OQ%Q:Q689-DBJ>SAS*K5:5^5UYJE3=KK6$%.5KJZETN>-X<
MT94<OSC.G3YG%.E26W,J,'5J*]G92E*$;I:.+WL>4Q_M9?ML?%N2?4/A9X,E
ML-%!_=KX1\`R>(+>!1R$FU[Q!%<P7%QC[WE+""<XC7H/:?!W`>2J-+-L<IU^
MOUC%J@WYJE1<)17:_-YMG+'BSC'-'*IE>!<**>GL,,ZB2[.I44HN7>UO0S-`
M_;H_:9^&GBI=(^+.CVNO0V4T2:WX;UWPO%X.\2P6SD,TEC<V,%LD5P8MQB:X
MM)X7Z9`.Y=<3X?\`"F9X-ULFKRPSFG[*M2KO$T'+M.,W)M7^)1G&2_`RH<<<
M19;BE1S2@JJIM>THU**P]9)]8N*BD[;.491?XGZS:M\1(=:^"6M?%#P'>1LM
MS\.M9\7>&;J[MEE6&YAT&[U"R6^LR^UI(+N(1SP%N'BD0GC-?CE'+'A\^H93
MF$''DQM/#UXQE;W75C"7)*VBE%WC*VS3L?JE7,(ULEK9G@9JTL)4KT925[-4
MI3CS1[J2M*-]TT?C-X2_;#\?3ZIKVK?$:32-4M#HFH7FGZ;I&BPZ1-?>))KF
MT^QP&YB>3[/:%9;IY20P5$+`%@JMYWB5]%?A;/'@ZO!L<5E>=9MG5.>9XS$X
MR>(PV&RZK'$U<=6IX1J$75]HJ4:%.,E>I.,&XP<I1\3A/QMSC+GB?[>=+$X'
M!X":PF'I453JUL7&5&.'IRK)OEARN;J3<7:*<DFTHRHG]LO]J7P\;.2UU*T\
M-:'))/-I>DW/@6S&E7$+S--+%!?:M9-=WR*TAW/%=AANS\N17Z]P;X2^'/#G
M#V%R#):U7-L-ESJ0EB99C&O7]M.I*=9S^K25"E+VLIOV2II4W>%G9GQN=^(G
M&./S*IF.-IPR^6)Y91H_4W2I\BBE!0=:+J37(H^_SMR^+2Z/U`_9T_:4OOCI
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M"5)3]BI8>6'NI<O/\27-9J.VWS/3O@;\:_VE?`_AOP[X2^'.@W-YX%377VW<
M7P^OM=3.HZJKZMG6;=?+.QY9L_\`/+&#]WCRL_R+A?'8K$XS,L1&GF'LE[KQ
M<*/P4[4_W3U5TE_B^9ZF1<1<1X+#8;"9;A9SP'M7:4<).JO?J7J?O(JVC;O_
M`"GZ-_M@?M">-?@+H/@[_A!?#FE:WK/C34M5TN"XU5+^[33IK&UM)XA:Z1IS
M1R:E=S_:7V)YR!?(Y63=@?F?!7#>`X@Q&-_M#%5,-0P$*=1QI\D.=3E)/FJ3
MNH1CRJ[Y6W?=6/T_BW/\9D-#!_4L/"M6Q<YPBYJ34'%1:M"%G)RYG;7IL[GP
M5JGQ]_X*%66FR^+;W1?$^D^'H(OMDUP?A+ID.F6UH!O,TZ76DRW<5H$Y,LK`
M!>2_>OT.CP[X:RJQP=.O0JXEOE4?[0J<\I;67+44'*_V4M^A\-5S_CR%-XJ>
M&K4<-%<S;P,5",>[O3<E'S>RU;/I#]DS]MG7_B?XKM/AG\5-/TBW\0:M!<-X
M9\4:)"^GVFJ7=I!)=S:5JNFR321VUY+:QS203VSK'(8#$8E=T9OF.,>!,-E&
M#GFF3U:CPU!I5\/5?-*G&3454IS23E%2:4XR7,K\W,TFE]!PKQI6S+%PRW,Z
M<(5ZJ?L:U-<L9R2<G"<&VE)Q3<91LG;EY4VK_8GQY^-&@_`?X>:CXXUF!]0N
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MH3BE&47LI)GHXKC_`!WU"@J5.&$S2E6E3Q-.5-\KBHWC.,9ZPO*\90;YHR6]
MFC[]_9)^)7C+XL_!;1O&_CJZL+O7[_6/$%M))INGQZ9:K:Z?J4MG:H+6.1PK
MA(B6;=\V:_.>,LJP.2Y[7R_+H3AAJ5.C)*<W.7-."E)\S2T;>Q]WPMF6*S7)
MZ.-Q;BZU2I5C[L5%6A-Q6BTZ'R9^T-^W+XML?&MS\+_V?M)L]4U6QU(Z'>>*
M)M.DU^?4->64P2Z3X4T2$^7>>3<!H6NYUG621'$41C3S9/L>&N`,%+`QS7B.
MM*A1G#VL<.IJBH4FKJIB*KUCS+WE"/*XIIRE=\J^3S_C?$T\;++,AHQJU:<_
M92K<KJ.=6]G"A36DK2T<FI*3ORJRYGXQ<?M7_MI_!G5M)N/BYX=%SI6I.TD.
ME^*_".GZ!'J4,85KF'3=;\.Q0BVO8XW!V2BX,993)"RY!]V/!_`F=4:T,EQ/
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MM17-"G!2Y)R/KVOC#ZP*`/YN_A9:E?B=\.3@\>.O"9Z8Z:]8&OZ<S:7_``E9
MGT_V7$?^FIG\@9'7?]M90K+7&X5?^5H'](E?S&?U^>,_M$KGX%_%9!W\$:Z!
M^-F]>YPUIG^4>6*I>7VD?.\7/EX8SU_RX.O_`.D,_,#]@:W\KXZ3-T_XH?7Q
MTQC-YH_M7ZKXAR_X0(K;_:J7_I-0_%/"NJY<3RC?_F"K_P#I=$^I_P#@H;'Y
MGPN\&KV'CR%L=!D:#K(!P._S'\Z^2\-WRYMC>G^R/_T[2/MO%R?L\CRYWY?]
MN7E_RXK%/_@G;%Y/P\\>KT'_``FD#`=!SH=B"?KP/RJ_$E_\*67_`/8,_P#T
M[(S\(9\V49KKMC(_^F8'S/\`\%#O$EYK/Q=T/PJ)'&G>$O"-K/#;;B(O[3\0
MW-Q=7ESMZ;VL[33(LXSB'WKZKPVPM/#9-B,7:U3%XB2;MKR48J,8^BE*H_F>
M'XF9G4_MNA@HRM3P>&C)1Z<]:4I2E;NXQ@OEYGTS\(/VL?V</AM\,?`_@F+6
M=8M)M`\.Z;:ZC%!X4UED;67MTN-;N#)%:E9GFU66\D,@)#&3()!%?*YUP?Q-
MF6:X_'.A3E'$5IR@WB*:M2O:DK.6EJ:BK=+'U.3<=<)Y;E6`P/UFI">'HPC-
M+#U?XKBG5=U&SYJCD[K>Y^<7QF\7>&=2^/7B'XC_``QN)TT:X\2Z-XLT>Z>S
MGTN9-8AATV_U*;[),JR0DZ[#>/DA=^\O_'7Z;D>#Q5'A[#97FL4J\:%7#U(J
M2FO9MSA!<RNG^Z<5Y;=#\QSS.<)4XAQ.8Y14?U:5:EB*<G%TVJB4)U'RNS7[
MU2>VN_4_>OQ=X?LOB3\.-=\.7**+3QCX4NK-=_(A?5M-)M9_9H9Y890>S1`U
M_/>"Q$\KS/#XF#M/`XB,M-+JG/WE_P!O)-/R9_16.PM/-LIQ.$DO<Q^&E%7^
MRZM/W9?]NR:DO-'XM_LFZW=_#K]HGPI:Z@&M/[2OM4\":S"Y\L)<:B)+."*3
MD8*:]:V'![K7[CQA0AF/#6+E2][V4:>+I-=H6DVO6E*9_.?`N93ROBW`T:R]
MG[>I4P56.UIU+PBGZ5XP/4/^"@7BHZY\5M#\*02,UKX*\,QO/$IRJZMXBE%_
M<?*.C_V;;Z1[_/[BO)\.<']6RBOBVN6>.KNSV_=T5R+_`,GE4/:\5<VY\]P^
M7P?N9=AXN2[5<0^=_P#E-4OO/T:^`W@:P^&_P*\'>&M62TMHXO#+:KXF-X8X
M;9;K7(Y=7UK[>\Q5%BA^V2PNTA"B.WY^45^9\08^IF6?XW$T')MU_9T.6[ER
MTFJ=+D2UO+E4DEJV^Y^O\+Y?#*.&LNPM=1I\N']KB.:RBI5DZM7G;LDH\[BV
M].6.NAY)XA_;:_9T\`!=!T*ZU'7;;2HQ:06_@?0(AH5I'!\@MK.[NYM/LC`F
M,`VK21X^Z2*]G#<"<2YA_M%>$,-*J^9O%5G[63>MY1BJE2[_`+Z4NYXN+\1.
M%,M_V?#U9XF-%<J6$HKV4;:6C*3I4[+^XW'LS\\_VLOCOX`_:`O?!FJ^$?#N
MN:1JOAVWUBPU2^UJ'3(7O]-O)+*?3;:)M/O[DNMO<QZ@X$A4+]M;;G<U?I'!
M_#^8\-T\=1QF)I5:.)=.=.%)S:A.*DIR:G"%N:+@M-^57V1^:\7\6Y9Q!/`U
M<OP]6A5PRJ1J2JJFN>$G%TTN2<_ADIO6UN;3=GW/^SS---^PYJ<,K%A:>#?B
MM9P`G.R!9/$DB(/]D&9@!V&!VKX'B2,8\>TG%6Y\3@)/IJU13^^Q^B<,UY3\
M/ZTV_P"'ALP2Z:1==H_+KX`>&]/UGXI>%[?4[>*YL[07NJ&WF17AFGTZPFN;
M02QL"KHMTL4FU@0?*`(P:KZ1_$.8\.^#W%N,RK$3P>,Q2PN!5:E)PJ4J6-Q5
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MU]Z1^4^%N(E/,<UI\WN_5J4K>:JM)_<V=+_P4?A,NK?"?`)"Z?XMP.@!:XT+
M)Q[X'Y5R^&,N2CF_3W\/Y?9JB\6ZOLJ^1]+PQ7R]ZB?2W[#"&+]GCPZGW=NN
M^*<#T!UFX/\`,D_C7R_'S_XR7$VT_=4/_3:/K_#6?-PIA);?OL3I_P!Q9'N'
MQ,\>?"[X;6NF>*?B1JFA:2]A)=CP_/J%LE[K`N9X56\3P_9PP37CW#PK&DKV
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ML?>>)N,Y,3E>#;]R%*K6M_>E)03^2B[>K[GTS^P+X2T[P]\`-,UNVMHH]1\8
MZYKVK:G=A%%Q<+I^I7.AV$$D@&XPP0:<QC0G"M<RL`#(Q/ROB'C*N(XBJX>4
MG[+`TJ5.G'91YX1JS:6R<G/5]4DNB/J/#_#4J/#U'$4XJ,\;5JU)RM9ODG*E
M%7[14'9;)MOJSY&_X*.>!-)TCX@>"?&FGVD-K=^,-#U*RUHP(L?VV^\.7%DM
MO?SA1\]R;'5(;=G/+)9P@_<K[+PRS"M5R['X&<VX8*K"5*^O)"LI<T%VCSP<
MDNCE+N?(>).%H83,,#C(04)8RE4C4MIS2HN%I/SY:BBWU45V/>/V?O$USX%_
M81U_Q-8,T-_H^F?$2;3I5)5H-0GU.^M;&=2,$&.[N(9!_N5\_P`1X6&.\0,/
MA)J].M/!J:[P4(2FOG%-?,]O(L>\!X?XK'4GRSP]/&.#VM-SE&+^4FF?$/[(
MWC?X;_"SXGW7C;XEW-U!%I_AR_M_#T\&F7>K2IKFHW-K!/=%+2-WBD&E_P!H
M)YK#_EZ<9R>?N^,L!F>;95#`95"-ZE:$JT7.-)>RA&34;R:37M.1V_NH_.^#
M,\RO*<UGC<WJ2IPIT9*BXTY5'[6<HIRM%-I^SYU?^\?5G[4W[2?P(^,/P>UK
MPGX?U75+[Q/%J.BZMX=CNO#>J64<=]9ZC`EV_P!LNK=$MLZ/<:FF2WS;]F#N
MKY'A+A?B#),ZH8O$484\(X5:=9QK4Y/DG!N*Y8MM_O%!^5K]#Z_BWC+AO-\E
MKX3!XBI/&1G2J45*A4@N:,TI>]**4?W;GZ[=1_\`P39UNYCM_BGX3DD;['!<
M>'?$-G$6.R&XNX]0TW4'5>BF5++3LX'/D\TO$^A#FRG&15IM5J,GM=1<)P^Y
MRG]Y?A9CIU5F^#;]V#H5HKLY*<)Z>?+#[C]2*_)S]="@`H`_G@^&-D5^)7P]
M;:?E\;^%3TQTURQ-?TEFM1?V7F*_ZA:_XTI'\3Y!4G_;N2JUO]OPG_I^F?T/
MU_-I_;!X_P#M`)N^"?Q10=_!>N`#ZVCU[7#CY<]RE[<N)I?^E(^8XSTX3X@M
MTP->W_@#/S5_86M3#\;)FP0/^$*UT>F,W>DU^H<?33R**7_052_])J'X/X0S
M;XLDFK+ZCB/_`$NB?3?[?D/F_#/P@H'W?'$1XXQ_Q(]7']:^5\.Y<F:8WI_L
MK_\`3M,^^\9FUD&66_Z#U_Z8K%3_`()_0^1X!\=+C&?&$!]/^8+9"K\1)7S'
M+[:6PS\O^7LC/P7;_L;-_P#L-C_Z8@?-?[>OA*[L?C%8>(C$_P!B\3^$M/%O
M/M(C^V:+-<V-Y;AL8\R.&2PD(]+E:^H\/<9">2U,,FE/"8B=X]>6JHRC+T;4
MU\F?)>+="I@N(Z&*<6J6/PE/DELN>A*4)Q]5%TY/RDCZO^#7[/7[-/Q#^&7@
MWQ5%\/=&O[R]T.PBUN4:IKGG1>(+2VBM];ANHX=6407`U!)V*;$^61&5=CJ3
M\AG?$?%&5YKC<&\RJ4H4ZLW27LZ5G1E)RI.+=/5<C6MWJFF[IGZ'PQPMP7GF
M0Y9F-/*J-:=:A!5FJM>\<1"*C7C)1JKEDJBD[66C32LT>CS_`+)7[-%LJ&X^
M&NA6ZRRQ6\1FU?7HA)/<,$A@C+ZR-\TCD*J#+,3@`FO,CQAQ0[J&:56XIR:5
M.B[):MNU+1):M[(]N?`?!E)+GR>C34I**YJU>-Y2=HQ5ZRO*3T26K>B/I&UM
MH+*VM[.UC$-M:016UO$I8B*""-8HHP6))"QHHR23QR:^8G*4Y2G)WE)N3?=M
MW;^\^RA"-.$*<%RPIQ48KM&*LE\DC\3?VG?"5S\./VA-<U;2T:UCU+4]+^(&
MBR(NQ5N;R=;R[:/;@`)KUG?\#L1ZU^Z<*8R&8\-T*-6TG1A4PE1?W8KEC?UI
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M,L36:Z+D;I1?6=1-7Y96_0?#;`/,/#/-L5*-L-@,OSFK+LZBAB73A_X$N9^4
M?-'QG^REX:?6?C9X5TU5\N.:TU@W+9`V6D.FS2W)'3YO*5E`]6%?H'CKP_/B
MKP_Q>10?+2Q69Y5*O+1<F%I8ZG5Q#7]YTHRC!=9RB?EW@CG$<NX_P&+:]ZE@
MLQ5-=ZLL).--/RYFFWV3/U&_:]@3_AG/X@6\:!(TM_#B(BC"JB>*=#"J!V`"
M@?A7SO`U.GA^(<II4HJE2HJI"$8JRA&.&J1C%+HDDDO(_5O$JK)<'9W5D^:3
M]@VWNW+%T+M^K=SXW_X)YVWV?Q[\0FV[<^$--'_E9S7W7B1+_A/RWRQ$_E^Z
M/S+P;K<^;YRMK8.D_P#RL=)_P4-MVEU3X6D`X6P\5#..,^?HAQ]?\:Y?#>2C
M1S;_`!X?\JIT>-,Y4\1P_P`NB=/%_P#I5#_,^B/V)3&OP#T6)'5F@U_Q/'*J
MD9CD;5))=C@?=;RY8VQZ.IZ&OF^.KKB&N[64J5!KT]FE=?-->J/M?"FHI\'8
M6SUCB,5%KL_:MV?9V:?HT^I^=/[4&I:AXW_:,\2V.MWLEMIVD:[I?@_3FE<^
M1HVC1_8HKB>"-_EB#SW-W>R-QN:3+'"C'Z5PI2IX#AK"SP\$ZE:E4Q,TM'4J
MOF<4VM[*,8+LEIUO^.<=9E5Q_&F.PV)JNG1PV(I8.G=VC1HKD4I)/17<YU9=
MV]=$C]>?!_P;^%/P^T6WT[P]X,\-65I96RF;4KO3;"ZU&Z\N,&6]U+5KN%IK
MF5PK2/(\FT;CM"K@#\:QN=YOF%>53$8ZO*<I:0C.<81N](PIQ:C%+9)*[ZW9
M_1V7\/9%E&&A1PF78>E3I1UJ2IPE4E9:SJ59IRDW\3;=M[)+0_&'PW/9:S^T
MWHFMZ9'$FFZG\;['4M/$")%"+*[\;)/:F&.-0J1&!T*JH`"D``"OW#%1G0X5
MKX>JW[6EE<X3O=OFCA6I7;UO>]_,_F/`YA1Q7'.$K4$E0KYW3G3Y=(\D\:G"
MR5DERM625K'T?_P4=\.7/_"2?#/Q0(V-C<Z)K7A]I0"%CN[*^@U*.-B/NM)#
M?S,H[B!\?=-?,>&6*BL+FF$3M.%6E62_NRBX-V\G%7]5W/TOQ9I2HXK)\9:U
M*=*M1OT4X351)^JFVN]GV/HO]@SQ7I^L?`ZV\-17$7]I^"]<UG3[VRWCSXK7
M5;Z?6]/NS'U$$POKF-7Z%[29>J&OFO$'!U*&?SQ3BXTL;2ISA*UES0@J4XW[
MQY4VNTD^I]5X9YC1Q?#D<+":]MEU:K"<+^\HU)NM"5OY9<\DGU<9+H?*_P#P
M4.\6Z7KGCSP7X1T^ZAN[GPAHNIW6L+!(&%C?^(+BS,-C,5R$NA9:9%.R'E5N
MHL_>X^M\-L'6PV7X[&3@Z<<95A&G=6YH4E*\U_=YJCBGU<7V/BO%/-</4S/+
M\OI5%*I@*52591=^2=>4;0=MI<E-2:W2E&^Y[5\#O"UUXL_85\0^&;"-I+W4
M=-\?"R@0$O/=VVK7E];6Z`=7EFMDC'NXKP\_Q<<%Q_AL54?+3I3PG,]E&,J<
M82?HE)M^A[V0X6IF/ACCL+03E5JTL=[.*WE.%2<XQ5NLI145YL^1_P!DSPC\
M,?%GQ.D\+?$_1++5K+6]"NHO#L&H75W91+XAM[FUN8X$DM+JW8W,VGK?HD;,
M=S($52[*#]CQAC,UP65+%Y37E0GAZL76<(QD_8RC*+=I1DE&,W!MI:)W;M<_
M,/#RGD>9Y\\MSO#PK4\50FL-&I.=-?6(RC)13C*#YITU448MZM62<FC]//\`
MAD/]G'_HEVD?^#+Q#_\`+BORK_7+B;_H;5/_``"C_P#*S]X_XA_P?_T)*7_@
MW$?_`"X[OX<_"#X4_#.[UB[^'/AG3-`N[Y8=-UF33[^_O';[(3<Q6ERMW?W`
M@EC-SOV@(V)E)X(KS\RSG-\SA0AF6*G7A2O.DIPA%+FT<H\L(W3Y;7U6AZ>3
M\/Y#DU3$SR?!T\+4J6IUG3J3F[P]Y0DISGRM<U[:.S5]&CU:O(/>"@`H`_'M
M?V./CG&RLFC>'XW0AD9/$]HCHP.0RLL8*,#R"""#7[+_`*Z9#:WMJUNJ]A*W
MW7/Y27A7QS%IQP6%BXZIK&P33[II:/S1>_X9+_:'_P">5G_X73?_`!=9_P"M
M_#G>7_A+_P``V_XAGX@_\^Z7_AQ_X)].?#'X*?$KPY\#_BOX&\0PVK^(_%BZ
M@NAPMKPU"W=;C1[>SC6:]D+"U4W$;Y!X`^;O7R^:9YEF(SW*,=A7*.&PG)[1
MJER-6J.3M%6YM&OR/T;ASA+B3`<&\3Y/F%.G_:.9*JL-'ZRJL'S4(P2E4=U3
M7.G^9R_[,_[/7Q+^%_Q'D\2>*]-TFTTIO#NIZ:);+6;:^F^U74]A)$OD1(&"
M%8),MG`P/6NGB?B/+,TRU87"5*DJJK0G:5-P7*E)/5]=5H>;X=\#\2\.\02Q
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M*-.A6KXI5::I58U4X>RA!MN*5GS)Z?,])^,GP?\`#GQE\*GP[K9>RO+28WNA
M:W;QI)=Z/J'EF,RHCD">UFC/ESVY91(N""KHCIYN2YSB<DQ?UC#I2A)<M6DV
MU&I"][.VTHO6,NCZ--I_1\5<+8'BK+7@<6W0JTI>TP^(BDYT*MK72=N:$E[M
M2FVE-6U4E&2_/:']F7]I?X:ZA=CX?ZI<?9IWPU_X1\7KH<=ZHXCDO--U&YM"
M)0N!AEFV]`Y`!K]$EQ3PQF5.']H48\T5I#$8?VCAW49P4]'Y<M^Q^%+@#Q%X
M>KU5D=64J<GK5P./6'4UT<Z-6=*SMW4[=)-'H/@#]GK]H;5/'W@_QA\2O$LG
MV/PKX@TO7!;^(/%=UXBNY%L;I)Y+>RL;.2>TMIY(PZ"1I4"[R>>A\[,.(^':
M.7XS!97A4IXNC.E>CAXT(KGBTG*4E&;2>MDG<]W(N"./<3G659IQ!CG"CEN)
MI8CEQ.-GBJC5.:DXTZ=-SI0E)72DYJU[Z[/](J_-#]^/CO\`:K^!/B7XL'PC
MJW@NST^YUK1O[1T[44OK^+3EDTJ[\JYMF2:5"':&\BF^3@XO&/8U]GPGGV&R
M?ZY1QLYPH5N2<.2+E:I&\9:+;FBUK_=1^4>)G!N9\2?V5BLEHTJF,PGM:555
M:JHIT9\LX-2::;A44M/^GC?0YC]EW]G3Q?\`#'Q?K?BOQQ8Z7:3IHHTK04L=
M2AU%O,OKE9=1N&,**("D%I#$,_>%U)CH:ZN*N),'F>#H8/`3J./M?:5>:#AI
M&-H)7>MW)M]N5'G>&W`F<</9IC,RSRA1H2CAU1PRI5HU7>I-.K)\J7+:,(Q5
M]U.1])_&?X4Z7\8O`][X2U"<V%RL\.IZ)JBQ^:=-U>U65;>=XMRF6VDBFG@F
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MK1[/1['3M:MYY;36[6\N$EO]-EMH%%O$@+`RN`Q!P.O(K^V^(^*,KS3*:V%P
ME2K[6K.E-1G2<+)34FF[M)I=-==+G\W<!<`\3\/\2X/,<SPN'I82A2Q$)2IX
MF%27-.E*$;023:<GOI9:GUW\>_!FM_$#X3^*_"'AR"WN-8U9-*6S@NKE+.W8
MVFMZ;?3>9<2`K'BWMI2,CD@#O7QW#^-H9;F^$QF(DX4:#J<SC'F:YJ4XJT5Y
MR1^I<;95C<ZX9S/+,NIPJ8S$JC[.,YJG%\F(I5)7F](^[&3\WIU/GW]E/X$?
M$#X2^)_%6J>,-/TNRM-6T&TT^S>PU:#4'>XAU#[0ZR1PHIB01\[CU/%?1<69
M_E^;X7"4L'4G.=&K*<E.FX))PY=&WW/AO#3@[/\`AG,<SQ&;X:CAZ6)PT*=-
MTJ\:K<XU>9IJ*5E;K\CU3]I/X'S?&;POID>CW5K9>)_#-U<WFC-?%X[&]@O8
MHX[_`$RYFBC=[;SOL]K)',$<+);J&7:[,OD\,YZLDQ55U82EA<3&,:BA;FBX
MMN$XIM)\MY)JZNI.SNDG]+X@<'U.*\MP\<'4A1S++ISG0]K=4ZD9Q2J49RBF
MX<_+"49V:4HI-6;:^*?!W[.W[3GAK4(],TD:AX9T6XU*SGU?^S_'5K8Z1=Q0
MSQ>=+/;:;J+27+&W0K_Q[[F7"GC@?;XSB3A?$4W5J\F)KQA)4^?"N52+:=DG
M."4=7?XK)ZGX_E7`_B1@,1'#8:E4R[!SJPE7]GF5.G0G%27-*4*55RE>*M_#
MYFM'H>Z?M)_LI:G\0/$4_C[P`]@=;U"""+Q!H%_.MC%J,]K"EM!J6GWK*8HK
MIK:.*.:&?RT?R5D$@9G#>%PSQ;2RW#1R['J2H4FW1JP7,X*3<G"<5KR\S;C*
M-VKM6M8^W\0/#;%YUCIYWD7LGBZ\8K$X6K)4E4E"*C&K2J-<D9N"49PGRQER
MJ2FFVGYYX6^!7[5/B.RMO!/B[QIK/A3P`(X['4(;GQ+9:I<-I*!4?3[.#3)9
MKBZC:$&-(KJ[C@`P&!0;#Z.*S_A3"5)8[!X&GBLPNY0<:$J:]H]5.3FHQB[Z
MN4(.7;74\#+.#_$S'TJ>49IF=?*LC25.HIXNG6E[%:.E3C1E.<TX^[&-2K&G
M;1WBN4H6?[(WQ$\+_%S3->\,Z1I<G@SP_P".-)U729;GQ#;#4&T/3M4M;I7G
M@>(.;OR(G++QN8'&`1C2?&.78K)ZN&Q-:<<;7PM2G44:+Y/:SA*+2:=E&[T?
M1&-+PRXAR[BC#XS+\'1EE&"S"C6HRGBX*J\/2K0G>47&_/RIW75['WA\8OA-
MX>^,W@F^\&Z^TEKOECOM(U:W1'N]%U>V5UM=0MT<A95VRRQ2PL5$L,\B94L'
M3X')<XQ.18ZGC<,E*R<*E-MJ-2G*W-!VVU2<9+6,DG9ZI_M_$>083B/+*N6X
MINEJIT:L4N>A6C?EJ13LFM7&4792A*2NFTU^947[%7[17A37)T\(Z]HUM;S`
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M:K?^(=0U^:6PEN[B.$ZA:V$3PS7=[&DEW<^;:2.\NQ0?-`&<;C\/Q)FN'S?,
M(XG"TI4:5.C"DE)1B_<E-IJ,6U&-I))7Z?(_8>`^'<?PQDM3`YEB*=?%5\34
MQ,G2E.:C[2%-.,IU%&4YW@W*5DG?K:[][KY\^U"@`H`*`"@`H`*`"@"G<6TT
MC+);WDUI(B[0JK'+;N,Y_>P2+R?]I&C;'&ZO/Q>#KUIPK87'U<%5IQY4DH5*
M$U>_[RC-:OIS4YTIVTY[:'11JTZ<7"KAX58-WNVX3CI]F<7IZ24H^1`)]1M^
M)[2.Z09_>V+A'P.YM;EEP?9)I#[5S_6<VPG^\X"&,IJ_[S!349V75X;$2C;T
MIXBJ^R-/982?\*NZ#_EK*Z^52FG_`.34X(>FIV6X(\WV63_GE=H]H^?0"=4#
M?\!)%53SO+>94ZF(^IU7_P`N\5&>%G?LE6C!2_[<<D^C9+P>(BKPI^T@OM4F
MJB_\D;M\TB^I!`*D$'D%2"#GT(KU(RBXJ4))Q>S337R:T.9IQ=FN5KIM86J$
M%`!0!7N+JVLT+W$\5N@&<R.J?D"<L?8"N/%YA@<OINIC<71PD(J]ZM2,/N3:
M;?DDVS2E1JU6HT:<IOM%-_EL<1J_CFVM5>/3(OM,N"!<3!H[=#_>5#AY?_'!
M[FOS'B#Q2P6#A4HY'0^N5U=*O64J>'@_YHP?+4J]TK4X^;1]%@.'*M5QEBY^
MQA_)"SF_)OX8_P#DS\CSM=*\1^++LW&R60.<&]NLPVD*9^[%\O*#/"0J??UK
M\FIY%QAQYCWBW3JUU-V>,Q-Z.%I0O?EI:).,;Z4\/"7GK=GU7UW*<CH>RO&G
MR;4:?O59/O+71O\`FFUY=CU3PUX-T[PZ//'^E:DZ[9+V1`OEAOO1VL?/D1GH
M3DLW<XX'[IP;X>Y1PC'ZRO\`;LXG'EGC*D4N1/XJ>&AJJ,'LW=U)KXY6?*OC
M<WS_`!>:OV7^[X.+O&C%[OI*H].>75*RC'HKZOKZ^_/!"@`H`*`"@`H`*`"@
M#Y>_:B^+'BWX1Z!X0UOPBUD)[OQ));:E!J5B;NPN].CTVYF>VN&1HY+3=/Y+
M++%-$^4P"02I^JX5RC!YOB,90QBERPHJ4'3ERSC-SBN9)W4M+W336OS/SGQ'
MXGS+A7`Y7C,L=.,ZN*<*L:M/GI3I*E.3A)IQE"\N5J491E=6NU=/Y_M/V][X
M6&V\^&=K)J03`EL_%#PZ>9".&\F;1Y)D3/.WS&/;=WKZ&?A_3]I^[S.4:5]I
M4$YV]544;^=EZ'PU+QNFJ-JN04WB$OBIXQQI7[\LJ$II>7,WYGROXDU3XC_M
M-?$F"9+`7^N7B0:9IFE:9',-(\.:1'*[CSIY"WV6RB>::XN+NX8%V=B!]R,?
M6X6GEO"F62CS^RH4VYSG-KVE:HTEHE:\FDHQA%:*WFS\ZQV-SWQ"X@@Z=%5\
M964:5*C14O8X6@FW[TG?DIQ<I3J59M.3;_NQ/V7^'G@ZT^'W@CPQX,L7\R#P
M[I%KIYGQM^U7*)OO;O;_``>?>23S;>WFX[5^*9CC9YCC\5C9KEEB:DI\O\L7
MI&/_`&[%)>=C^K\CRNED>49=E-%WA@*$*7-MS22O4G;ISS<I6Z7.RKB/5"@`
MH`*`"@`H`*`"@`H`*`"@`H`*`&NB.I1T5D/574,ISZJ1BHJ4Z=2#IU:<:D'O
M&45*/S330XRE!IP;@ULT[-?<4#I-@"6C@^S-_>M9)+4@^N('09_"O)GP_E/,
MYTL+]3G_`#86I5PK3[VH3IQOZIG0L9B+6=3G7:HHS_\`2TV`T]T_U=_?I[-*
MDH'_`']C)_6L_P"Q*L/]WSO,:/92JTZR_P#*U*<O_)@^L1>^'I?*+C_Z3)+\
M`-I>`8749!]8(B1_WSMK*64YO:T.(JT>W-AJ#?\`Y+R$JI2_Z!UZ*37^93ET
MJ]DRK:O<*O\`=2+9_P"@S"O.K\-9Q73C4XJQ*@_LPH^S_P#2*Z_(WIXJA3M;
M!P;7>7_VIGGPA9R-NN+N[E/?!C3]2K']:\M>&V6SGSXS,L9B9=7S4X-_.4:D
MO_)K^9UK.JU-<M&A3II>3=ODG%?@7[7PSHEFRO'8QR2+TDN<W#9]0)25!^BB
MO=R_@GAG+91G1RNG6K0U53$7KROW2J.4(OSC%&%7-LPJIQ>(E3A_+3M!?^2V
M?WLW0`H"J`H48``P%'H`.@KZE)02C%*,8JR25DEV26R/-;=[O<6F`4`%`!0`
M4`%`!0`4`%`%>ZM+6]@DM;RVM[NVD&V6VNH8YX)%/\,D,JLCCV(-5"<Z4E*G
M)TY1V<6XM>C5FC.I2I5H2I5J<:M.6CA.*E%KSC)-/YH\YO/@K\([Z<W%U\-_
M!KS%MS.N@:=!ECR2RP0(I)/J*]*&=YO2CR0S+$QBME[6;M][=CYZMP;PI7G[
M2KP[E[FW>ZPM*.OFHQ2_`[+0O#/ASPO;&S\.:#H^@VIQN@TC3K33HW(SAI%M
M84\QN3\S9//6N*OBL3B9<V(KU*\ELZDY3:].9NWR/8P.6Y?E=/V.78&A@:3W
;C0I4Z*?JH1C=^;NS<K`[0H`*`"@`H`*`/__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
